🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

10 suggested action items for physician colleagues suffering under the burden of American Board of Internal Medicine (ABIM) MOC. #MedTwitter 1. If your institution allows it, stop participating in MOC. Personally, MOC has no value to me.

4. Urge professional societies in your discipline to End MOC. We should assess societies by their actions not their words. We are dues paying members. Society leadership should listen to their members. Consider quitting societies that are not sincere in efforts to end MOC.

This male sumatran orangutan is Raku: he got a wound on his right cheek. Scientists were surprised to spot him applying a medicinal plant on his face: akar kuning (Fibranaurea tinctoria), a type of climbing vine that acts as an analgesic. After about 8 days he applied the chewed

MRD negative status (10e-5 to -6) 1 year after AutoHCT and Len maintenance is associated with longer PFS and OS in MM. STaMINA trial #bmtsm #mmsm Marcelo Pasquini BMT CTN Theresa Hahn, PhD Phari Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Serendipitous encounters have really encapsulated my 1st #ASCO24 experience! Finally met our former MCW Cancer Center MCW Hematology & Oncology division chief Phari who is an amazing mentor to so many including my mentor Bilal Abid, MD, MS and who helped review my first #mmsm pub! What an honor!

Next generation CAR with novel binding domain! Deep and durable response in high risk patients! Look forward to getting this to our patients! ⁦MCW Cancer Center⁩ ⁦European Hematology Association⁩ #eha2024

To use a CAR-T metaphor Biden looked like he had ICANS with word finding difficulty and needed dexamethasone. Trump looked like the orderly pretending to be a doctor and ready to take over. There should be talk of an open Democratic convention. That seems like a logical step.

Our new paper in NEJM examines the widespread acquisitions of medical practices by UnitedHealth, Humana, Cigna, and other insurers—what’s driving this trend and what are its implications for patients and clinicians? 1/x

Dara-VRd and Dara-KRd quadruplets as initial therapy for high risk myeloma. Griffin trial and Master Trial. Natalie Callander Susan Bal Robert Z. Orlowski Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Phari Nina Shah @tanyawildes #OpenAccess nature.com/articles/s4140…

Checkmate 067 10 year data 🚨 presented by James Larkin with concurrent NEJM publication. 10 years of ipi+nivo revolutionizing melanoma care and changing the way we treat cancer!! 10y MSS is >50%! #ESMO24 OncoAlert nejm.org/doi/abs/10.105…

6/ #ASH24 Abstract 931 (Dhakal) bsAbs and CAR-T are friends, not foes! Talquetamab bridging before BCMA CAR-T. @end_myeloma: "Only place where BCMA must precede GPRC5D is dictionary." In real life, tal's one of the best #MMsm bridging tools we have! ash.confex.com/ash/2024/webpr…

ash.confex.com/ash/2024/webpr… Excited to share CAR20.19 multicenter data--a nearly 10 year effort. Developed a Phase 1 trial with this construct in 2016, first patient treated at MCW in 2017. Published Phase 1 with target dose, fresh-in/fresh-out CAR cells in Nature Med in 2020.

👉#ASH24 wonderful to meet Phari and Saurabh Chhabra Dr Hari was my first mentor during internal medicine residency at Medical College of Wisconsin 🙏🏽🙏🏽

And of course bumping into our Medical College of Wisconsin crew at ASH-a-Palooza! Phari and my former co-resident who is now a 2nd year Heme/Onc fellow at Loyola Heme/Onc #ASH24 #ASHTrainee

Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma | Journal for ImmunoTherapy of Cancer ⁦MCW Cancer Center⁩ ⁦⁦Saurabh Chhabra⁩ ⁦Phari⁩ jitc.bmj.com/content/13/1/e…

⁦Nirav Shah⁩ presenting CD19.20 CAR-T in DLBCL- a phase 2 registration study with POC manufacturing ⁦Medical College of Wisconsin⁩ #tandem25

Thank you ⁦Anant Madabhushi⁩ and his colleagues from ⁦Emory University⁩ for this must read - excellent review for clinicians on Artificial Intelligence ascopubs.org/doi/10.1200/OP… ⁦JCO Oncology Practice⁩ ⁦OncoAlert⁩ ⁦Jeffrey peppercorn MD⁩

From Lab to Startup: Dr. Simrit Parmar on Launching Cellenkos youtu.be/TbYwHukA2Ik?si… via YouTube The world of startups is hard and filled w challenges. The inspiring journey of simrit parmar shows tenacity and perseverance that we can all learn from. My last #HealthcareUnfiltered

Truly honoured to be AACR & speak on #Precision in #RareCancers “A view from India”. Amazing to share the stage with the great Razelle Kurzrock, MD and Young Kwang Chae, MD, MPH, MBA #DART ! Umut. Dişel Sangeeta Goswami, MD,PhD thank you for being the audience! 🙏 Sir H. N. Reliance Foundation Hospital OncoAlert OncoDaily

AACR Vivek Subbiah, MD Aung Naing Geoff Oxnard MD Robert Haddad Glenn J. Hanna, M.D. Sangeeta Goswami, MD,PhD Toni Choueiri, MD Phari But truly overjoyed and overwhelmed by Aditya Shreenivas MD MS #OralPresentation #Penpulimab #NPC Razelle Kurzrock, MD Vivek Subbiah, MD Balazs Halmos Aung Naing Phari Glenn J. Hanna, M.D. OncoAlert OncoDaily Oncology Brothers #BrotherSisterGoals